Literature DB >> 20196298

Isolating the effects of vection and optokinetic nystagmus on optokinetic rotation-induced motion sickness.

Jennifer T T Ji1, Richard H Y So, Raymond T F Cheung.   

Abstract

OBJECTIVE: This study investigates isolated effects of vection and optokinetic nystagmus (OKN) on visually induced motion sickness (VIMS) provoked by rotating optokinetic drum patterns.
BACKGROUND: VIMS was the subject of recent standardization activities, but the effects of OKN have not been studied in the absence ofvection.
METHOD: Experiment 1 suppressed OKN by eye fixation and examined VIMS severity (both ordinal and ratio scale) and time spent in saturated vection at four pattern rotating velocities of 0, 2, 14, and 34 degrees per second (dps). Experiment 2 suppressed vection by adding a peripheral visual field rotating in the opposite direction to the rotating patterns. VIMS severity and OKN slow-phase velocity were studied at four rotating velocities of 0, 30, 60, and 90 dps.
RESULTS: Results from Experiment 1 indicated that VIMS severity increased as the pattern velocity increased from 0 dps to 34 dps. Results from Experiment 2 indicated that as the velocity of the rotating pattern increased, the slow-phase velocity of OKN and the severity of VIMS increased and peaked in the 60-dps condition. In both experiments, ratio-scaled nausea data significantly correlated with ordinal-scaled nausea ratings.
CONCLUSION: VIMS can still occur in the absence of either vection or OKN. Interestingly, the profile of the summed results of the two experiments matches nicely with the profile reported by Hu et al. in which neither OKN nor vection were controlled. APPLICATION: Potential applications include modeling and reduction of VIMS in computer gaming environments.

Entities:  

Mesh:

Year:  2009        PMID: 20196298     DOI: 10.1177/0018720809349708

Source DB:  PubMed          Journal:  Hum Factors        ISSN: 0018-7208            Impact factor:   2.888


  9 in total

1.  Predicting vection and visually induced motion sickness based on spontaneous postural activity.

Authors:  Stephen Palmisano; Benjamin Arcioni; Paul J Stapley
Journal:  Exp Brain Res       Date:  2017-11-27       Impact factor: 1.972

2.  A Pilot Study on EEG-Based Evaluation of Visually Induced Motion Sickness.

Authors:  Ran Liu; Miao Xu; Yanzhen Zhang; Eli Peli; Alex D Hwang
Journal:  J Imaging Sci Technol       Date:  2020-01-31       Impact factor: 0.400

3.  Combined effects of auditory and visual cues on the perception of vection.

Authors:  Behrang Keshavarz; Lawrence J Hettinger; Daniel Vena; Jennifer L Campos
Journal:  Exp Brain Res       Date:  2013-12-04       Impact factor: 1.972

4.  Vection and visually induced motion sickness: how are they related?

Authors:  Behrang Keshavarz; Bernhard E Riecke; Lawrence J Hettinger; Jennifer L Campos
Journal:  Front Psychol       Date:  2015-04-20

5.  Demonstrating the potential for dynamic auditory stimulation to contribute to motion sickness.

Authors:  Behrang Keshavarz; Lawrence J Hettinger; Robert S Kennedy; Jennifer L Campos
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

6.  The Oscillating Potential Model of Visually Induced Vection.

Authors:  Takeharu Seno; Ken-Ichi Sawai; Hidetoshi Kanaya; Toshihiro Wakebe; Masaki Ogawa; Yoshitaka Fujii; Stephen Palmisano
Journal:  Iperception       Date:  2017-11-24

7.  Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories.

Authors:  Suzanne A E Nooij; Paolo Pretto; Daniel Oberfeld; Heiko Hecht; Heinrich H Bülthoff
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

8.  Beyond sensory conflict: The role of beliefs and perception in motion sickness.

Authors:  Suzanne A E Nooij; Christopher J Bockisch; Heinrich H Bülthoff; Dominik Straumann
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

9.  Human Vection Perception Using Inertial Nulling and Certainty Estimation: The Effect of Migraine History.

Authors:  Mark A Miller; Catherine J O'Leary; Paul D Allen; Benjamin T Crane
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.